Related Experiment Video
Updated: May 1, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
The 129S1/SvlmJ mouse strain recapitulates severe hypertensive target organ damage under moderate angiotensin
Arthur Orieux1,2, Romain Boulestreau1,3, Marie-Lise Bats1,4
1Univ. Bordeaux, INSERM, BMC, Pessac, U1034, F-33600, France.
Insights
Genetic background significantly impacts hypertension complications. The 129S1/SvlmJ mouse strain shows severe organ damage, unlike C57BL/6J, making it a better model for studying hypertensive target organ damage.
Area of Science:
- Cardiovascular Research
- Genetics and Genomics
- Nephrology and Urology
Background:
- Hypertension is a primary cause of widespread vascular damage.
- Genetic factors influencing organ-specific vulnerability to hypertension are not well understood.
- Common mouse models like C57BL/6J do not fully replicate human hypertensive complications.
Purpose of the Study:
- To compare hypertensive organ damage in C57BL/6J and 129S1/SvlmJ mouse strains.
- To identify a more suitable mouse model for studying hypertensive target organ damage.
- To investigate the role of genetic background in hypertension-induced organ injury.
Main Methods:
- Induction of moderate hypertension via chronic angiotensin II infusion in both mouse strains.
- Assessment of blood pressure and detailed evaluation of target organ damage (brain, retina, heart, kidneys).
- Transcriptomic analysis of cerebral microvessels to compare molecular signatures.
Main Results:
- Both strains experienced comparable blood pressure elevation.
- 129S1/SvlmJ mice exhibited severe organ damage, including cognitive deficits, blood-brain barrier disruption, retinal vasculopathy, cardiac hypertrophy, and kidney podocyte lesions.
- C57BL/6J mice showed significantly less organ injury.
- Distinct inflammatory and immune gene expression profiles were observed in cerebral microvessels between strains.
Conclusions:
- Genetic background critically influences the severity of hypertensive complications.
- The 129S1/SvlmJ strain serves as a more relevant and translational model for hypertensive target organ damage.
- This model facilitates research into pathways linking genetic susceptibility, vascular injury, and end-organ damage in hypertension.
Abstract:
Hypertension remains the leading cause of cerebral, cardiac, renal, and retinal vascular damage. However, genetic determinants underlying organ-specific vulnerability are poorly understood, and commonly used mouse models, notably C57BL/6J, often fail to recapitulate severe hypertensive complications seen in humans. This study compares the widely used C57BL/6J mouse strain with the genetically distinct 129S1/SvlmJ strain under hypertensive stress, aiming to identify a model that better reproduces hypertensive target organ damage. Moderate hypertension was induced in 129S1/SvlmJ and C57BL/6J mice using chronic infusion of angiotensin II (600 ng/kg/min). Despite comparable blood pressure elevations, only 129S1/SvlmJ mice developed severe organ damage, including cognitive impairment, pronounced blood-brain barrier disruption, retinal vasculopathy, cardiac hypertrophy, and podocyte lesions with albuminuria. In contrast, C57BL/6J mice exhibited markedly less organ injury under the experimental conditions tested. Transcriptomic analysis of cerebral microvessels identified distinct inflammatory and immune-related signatures between strains, paralleling their vascular phenotypes. These immune profiles appear as hallmarks of strain-specific susceptibility rather than as direct protective or deleterious mechanisms. This study demonstrates that genetic background critically shapes hypertensive complications, identifying the 129S1/SvlmJ strain as a relevant and translational model of hypertensive target organ damage. Beyond reproducing key features of severe hypertension, this model provides a framework to investigate the pathways linking genetic susceptibility, vascular injury, and end-organ damage.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension II: Pathophysiology

